MedPath

Analysis of volatile organic compounds in exhaled air as a non-invasive biomarker for liver diseases

Recruiting
Conditions
Hepatitis
10019654
liver diseases
Registration Number
NL-OMON36737
Lead Sponsor
niversiteit Maastricht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
180
Inclusion Criteria

- A clearly defined diagnosis of liver diseases based on laboratory, radiological and histological characteristics
- Age between 18 and 85 years

Exclusion Criteria

- Inflammatory bowel diseases (IBD)
- Chronic obstructive lung disease (COPD), lung cancer, asthma
- Rheumatoid arthritis (RA)

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary outcome is to identify VOC profiles in exhaled air that are unique<br /><br>for specific liver diseases.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>To compare the VOC profiles in exhaled air between patients with liver diseases<br /><br>and versus healthy controls.<br /><br>To compare the VOC profiles before, during and after therapeutic interventions<br /><br>in various liver diseases (e.g. viral hepatitis, auto-immune hepatitis, NAFLD).<br /><br>To compare VOC profiles with systemic inflammatory and oxidative stress<br /><br>markers.<br /><br>To identify specific metabolites in VOC profiles to gain insight into the<br /><br>pathogenesis of liver diseases.</p><br>
© Copyright 2025. All Rights Reserved by MedPath